BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spartan Bioscience DX-12(TM) DNA Analyzer Now Available


5/18/2009 11:08:51 AM

ATLANTA, GEORGIA and OTTAWA, ONTARIO--(Marketwire - May 18, 2009) - The Spartan DX-12™ DNA analyzer, developed and manufactured by Spartan Bioscience Inc. is now available for world-wide commercial use. Priced at less than $12,500 U.S., the DX-12 is affordable for all laboratories. Designed for non-batched PCR applications, the DX-12 is an easy-to-use, lightweight stand-alone instrument that produces both qualitative and quantitative results typically in 30-60 minutes.

"The commercial release of the Spartan DX-12 is the culmination of 3 1/2 years of intense development," said Mark Kershey, President, Spartan Bioscience. "We are pleased that the first clinical validation of the instrument was completed by the Children's Hospital of Eastern Ontario (CHEO) and presented last month at the Clinical Virology Symposium in Florida and this validation has generated significant interest in our on-demand PCR analyzer. Our existing orders for the DX-12 will start shipping in June and the resellers that have been waiting for this device are being contacted to set the stage for global shipments."

Key operating features of the Spartan DX-12 include:

- 12-well sample capacity and dual-channel optical detection

- Performs 2 or 3 temperature PCR programs

- Small size means minimal bench footprint

- Fully stand-alone; no computer required to operate or interpret results

- Built-in Reverse Transcription (RT) program for RNA analysis

- Melt curve analysis

- Quantitative analysis

- Compatible with leading reagents and kits

Spartan will be showcasing the DX-12 at the BIO International Convention in Atlanta, GA, May 18-21, 2009, in the Province of Ontario Pavilion booth # 3311.

About Spartan Bioscience

Spartan Bioscience Inc. is a privately-held molecular diagnostic instrumentation company developing, manufacturing, and marketing DNA analyzers for on-demand applications. Founded in 2005, the company focus is on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments or time-critical diagnostic testing for infectious diseases. Other applications include human genetics, veterinary, food and water safety, and many others. The company is headquartered in Ottawa, Canada. For more information visit the website at www.spartanbio.com.


Contacts:
Spartan Bioscience Inc.
Shelley Mullins
PR and Communications
613-866-8803
shelley.mullins@spartanbio.com
www.spartanbio.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES